SCHEMBL7999831

SCHEMBL7999831

CC(C)(C)CC(=O)Nc1nc(Cl)ccc1C(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.41
ADORA2A P29274 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 4/20 0.37
RAB9A P51151 3/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
KCNQ3 O43525 5/20 0.36
KCNQ2 O43526 5/20 0.36
XPO1 O14980 1/20 0.36
ADORA1 P30542 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
KCNQ4 P56696 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1514134 0.80 XPO1 (0.41) GAAMAPTXPO1MEN1KMT2A
SCHEMBL7965692 0.80 ATR (0.42) RAB9AGAAXPO1MEN1KMT2A
SCHEMBL25310109 0.69 GPR27 (0.40) HTTGAAXPO1MEN1KMT2A
SCHEMBL14684399 0.68 NNMT (0.37) SMN1; SMN2L3MBTL1RAB9AMEN1KMT2A
SCHEMBL26803352 0.66 SLC6A12 (0.39) XPO1
SCHEMBL22693561 0.66 S1PR2 (0.56) ADORA2ASMN1; SMN2HTTL3MBTL1HPGD
SCHEMBL16084274 0.66 CSNK1D (0.39) CSNK1DSMN1; SMN2HTTL3MBTL1HPGD
SCHEMBL5374156 0.66 L3MBTL1 (0.42) SMN1; SMN2HTTL3MBTL1HPGDRAB9A
SCHEMBL1119560 0.66 TUBB4A (0.33) HTTXPO1
SCHEMBL1169061 0.64 MAPT (0.40) SMN1; SMN2HTTL3MBTL1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009138176-A1 SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AS GSK3BETA-INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-11-19 WO disclosed